Alzheimer's Biomarkers, Ebola Travel Suspensions, and AI in Medical Admissions
Listen to episode
About this episode
In this episode, Dr. Chi-Ming Chow delves into the early signs of Alzheimer's disease, examining the impact and limitations of current biomarkers and the role of demographic factors and blood-based biomarkers. He discusses Canada's travel suspensions amid the Ebola outbreak, highlighting the measures taken and the criticisms faced. The episode also explores brain changes related to speech comprehension and cognitive decline, focusing on the limitations and implications of a recent speech-in-noise study. Dr. Chow considers the influence of AI on medical school admissions, touching on authenticity, letters of recommendation, and the activities section, as well as the impact on secondary essays. The episode wraps up with Dr. Chow's closing remarks.
(0:00) Introduction and early signs of Alzheimer's disease
(1:05) Impact and limitations of Alzheimer's biomarkers
(2:28) Demographic factors and blood-based biomarkers for Alzheimer's
(3:17) Canada's travel suspensions related to Ebola
(4:20) Travel suspension measures and criticisms
(5:34) Brain changes, speech comprehension, and cognitive decline
(7:58) Limitations and implications of the speech-in-noise study
(9:11) Impact of AI on medical school admissions
(10:15) Authenticity, letters of recommendation, and activities section
(11:45) AI's influence on secondary essays and overall admissions process
(12:42) Closing remarks and episode conclusion
More AI podcast episodes
Browse all →Want to find AI jobs?
Join thousands of AI professionals finding their next opportunity